RBC Bioscience Corporation
6848
Rank in Stocks
#29117
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Share Price
$0.61578607
Last synced: 2026-11-10
Market Cap
$8.79M
Change (1 day)
-1.94%
Change (1 year)
8.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RBC Bioscience Corporation (6848)
Category
Healthcare
Operating Margin for RBC Bioscience Corporation (6848)
Operating Margin as of November 2026 TTM: 12.13%
According to RBC Bioscience Corporation's latest financial reports, its current operating margin (TTM) is 12.13%. At the end of 2025 the company had an operating margin of 15.94%.
Operating Margin history for RBC Bioscience Corporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.13% | -23.90% |
| 2025 | 15.94% | -8.60% |
| 2024 | 17.44% | 106.88% |
| 2023 | 8.43% | 89.01% |
| 2022 | 4.46% | -76.95% |
| 2021 | 19.35% | -40.92% |
| 2020 | 32.75% | 171.33% |
| 2019 | 12.07% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -96.82% |
US
|
|
| -149.01% | -112.28% |
US
|
|
| 25.57% | -97.89% |
AU
|
|
| 31.23% | -97.43% |
BE
|
|
| 29.35% | -97.58% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about RBC Bioscience Corporation's operating margin
What is RBC Bioscience Corporation's operating margin?
RBC Bioscience Corporation's operating margin is 12.13%, as of Nov 2026.
What was RBC Bioscience Corporation's operating margin in 2025?
In 2025, RBC Bioscience Corporation's operating margin was 15.94%, compared with 17.44% in 2024.
How has RBC Bioscience Corporation's operating margin changed since 2020?
From 2020 to 2025, RBC Bioscience Corporation's operating margin was highest in 2020 (32.75%) and lowest in 2022 (4.46%).
How does RBC Bioscience Corporation's operating margin compare with similar companies?
RBC Bioscience Corporation's operating margin (12.13%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.